Profusa
PFSA | NASDAQ
$0.45
-$0.10 (-18.18%)
At close: Nov 12, 2026, 3:59 PM ET
$0.46
+$0.01 (+1.47%)
After-hours:
Nov 12, 2026, 7:52 PM ET
-18.18%
(1D)No price chart data available for 1D timeframe.
Rating
19.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1001/1025 (Top 98%)
Key Statistics
Market Data
Market Cap $2.08M
1D Range
0.42 0.54
52W Range
0.42 1,488.00
Valuation (TTM)
PE 0
PB -0.08
EV/EBITDA -0.44
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Cash Flow
FCF Yield -1010.7%
SBC Adj. FCF Yield -1019.7%
SBC Impact -0.9%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -8.4% |
N/A
FCF 3Y | 5Y -78.2% |
N/A
Returns
ROA -4123.8%
ROE 148.3%
ROIC 242.6%
Financial Health
Net Debt
$13.29M
Current Ratio 0.03
Interest Coverage -6.03
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. I...
Sector Healthcare
Industry Medical - Devices
Employees 2
IPO Date Jul 14, 2025
Website profusa.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove PFSA